Drug shortage
Extended Release · Teva Pharmaceuticals USA, Inc.
FDA drug shortage · Current · updated Oct 1, 2026
Key facts
| Generic name | Extended Release, Methylphenidate Hydrochloride Tablet |
|---|---|
| Company | Teva Pharmaceuticals USA, Inc. |
| Presentation | Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01) |
| Dosage form | Tablet |
| Status | Current |
| Reason for shortage | Other |
| Therapeutic category | Psychiatry |
| Package NDCs | 62037-726-01 |
| First posted | Jul 26, 2023 |
| Last updated | Oct 1, 2026 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: